Bolt Biotherapeutics, Inc. (BOLT) — 10-Q Filings
All 10-Q filings from Bolt Biotherapeutics, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Bolt Biotherapeutics Narrows Loss Amid Revenue Dip, Going Concern Doubt
— Nov 12, 2025 Risk: high
Bolt Biotherapeutics, Inc. reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $26.745 million, compared to $47.1 -
Bolt Biotherapeutics' Losses Narrow, But Going Concern Doubts Persist
— Aug 14, 2025 Risk: high
Bolt Biotherapeutics, Inc. (BOLT) reported a net loss of $19.601 million for the six months ended June 30, 2025, a significant improvement from the $32.006 mill -
Bolt Biotherapeutics Files Q1 2025 10-Q
— May 12, 2025 Risk: medium
Bolt Biotherapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported on its financial position and business operations. Key fina -
Bolt Biotherapeutics Files Q3 2024 10-Q
— Nov 12, 2024 Risk: medium
Bolt Biotherapeutics, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported research and development expenses for the third quarter -
Bolt Biotherapeutics Files Q2 2024 10-Q
— Aug 13, 2024 Risk: medium
Bolt Biotherapeutics, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported on its financial condition and results of operations, includ -
Bolt Biotherapeutics Files 10-Q for Period Ending March 31, 2024
— May 14, 2024 Risk: medium
Bolt Biotherapeutics, Inc. (BOLT) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. Bolt Biotherapeutics, Inc. filed a 10-Q report for the period en
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX